BGI Education Center, University of Chinese Academy of Sciences, Shenzhen 518083, China; BGI-Shenzhen, Beishan Industrial Zone, Shenzhen 518083, China; Shenzhen Key Laboratory of Single-Cell Omics, BGI-Shenzhen, Shenzhen 518100, China.
BGI-Shenzhen, Beishan Industrial Zone, Shenzhen 518083, China.
Genomics Proteomics Bioinformatics. 2021 Jun;19(3):346-357. doi: 10.1016/j.gpb.2021.03.008. Epub 2021 Jul 17.
Single-cell genomics provides substantial resources for dissecting cellular heterogeneity and cancer evolution. Unfortunately, classical DNA amplification-based methods have low throughput and introduce coverage bias during sample preamplification. We developed a single-cell DNA library preparation method without preamplification in nanolitre scale (scDPN) to address these issues. The method achieved a throughput of up to 1800 cells per run for copy number variation (CNV) detection. Also, our approach demonstrated a lower level of amplification bias and noise than the multiple displacement amplification (MDA) method and showed high sensitivity and accuracy for cell line and tumor tissue evaluation. We used this approach to profile the tumor clones in paired primary and relapsed tumor samples of hepatocellular carcinoma (HCC). We identified three clonal subpopulations with a multitude of aneuploid alterations across the genome. Furthermore, we observed that a minor clone of the primary tumor containing additional alterations in chromosomes 1q, 10q, and 14q developed into the dominant clone in the recurrent tumor, indicating clonal selection during recurrence in HCC. Overall, this approach provides a comprehensive and scalable solution to understand genome heterogeneity and evolution.
单细胞基因组学为剖析细胞异质性和癌症进化提供了大量资源。遗憾的是,基于经典 DNA 扩增的方法通量低,且在样本预扩增过程中会引入覆盖偏差。为了解决这些问题,我们开发了一种无需预扩增的纳升级(scDPN)单细胞 DNA 文库制备方法。该方法在进行拷贝数变异(CNV)检测时,最高通量可达每运行 1800 个细胞。此外,与多重置换扩增(MDA)方法相比,我们的方法显示出更低的扩增偏差和噪声水平,对细胞系和肿瘤组织评估具有较高的灵敏度和准确性。我们使用该方法对配对的原发性和复发性肝癌(HCC)肿瘤样本中的肿瘤克隆进行了分析。我们在整个基因组中发现了三个具有大量非整倍体改变的克隆亚群。此外,我们观察到原发性肿瘤中一个含有 1q、10q 和 14q 染色体额外改变的小克隆在复发性肿瘤中发展为优势克隆,表明 HCC 复发过程中存在克隆选择。总的来说,该方法为全面了解基因组异质性和进化提供了一种综合且可扩展的解决方案。